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1. Introduction 
The ‘H NMR spectra of purified human hemoglo- 
bins have been widely studied in the region of para- 
magnetically shifted resonances [l-12]. In the 
aromatic region, 3 histidine C2 resonances have been 
assigned [13-141, some pK-values obtained [ 15-181 
and relaxation times measured [ 141. However, studies 
on intact red cells have been scarce [ 19-24,411. 
Interest has been focused mainly on the binding of 
2,3-diphosphoglycerate (DPG) to hemoglobin in the 
deoxy-state, while the binding to the oxy state has 
received much less attention. Conclusions regarding 
to the latter are contradictory, depending on the phys- 
ical technique used in its study 125-361. 31P Studies 
on intact erythrocytes support the claim that 2,3-DPG 
binds to oxyhemoglobin [ 191. 
Here we have studied ‘in vivo’ binding of 2,3-DPG 
to oxyhemoglobin by observing the changes in the 
histidine C2 resonances originated by an increase of 
the 2,3-DPG concentration inside the cell. The corre- 
sponding spectral region has been simplified by means 
of the spin-echo technique [37], which has proven to be 
useful in erythrocyte NMR studies [9,17,20-2 1,241. 
2. Experimental 
Blood from a local bank was washed twice with 
‘Hz0 Krebs/Ringer buffer [38] pre-gassed with an 
OZ/COZ mixture (19: l), and split into 15 ml samples 
(25% hemoglobin). An increase in the 2,3-DPG level 
was obtained by incubating at 37’C with 40 mM ino- 
sine, 50 mM Pi and 10 mM pyruvate [39]. A reference 
blood sample was incubated for 3 h without any addi- 
tion. To avoid lysis of cells due to the growing of bac- 
teria during the incubation and NMR measurements, 
the material was autoclave-sterilized, and buffer solu- 
tions illtered through millipore GS 0.22 pm filters. 
Blood samples were then washed again, once with 
‘Hz0 Krebs/Ringer buffer, and 5 times with 2H20 
Krebs/Ringer buffer pre-gassed with the 02/C02 mix- 
ture, so that substrates in excess were eliminated, 
‘H20 exchanged by 2H20 and hemoglobin kept in 
the oxy-state. [Hemoglobin] was -80%. Aliquots 
were precipitated with trichloroacetic acid and subse- 
quently analyzed for 2,3-DPG content by the enzymic 
method in [40]. Before the samples were transferred 
to NMR tubes, the pD was measured on a Radiometer 
pH meter. After immediate recording of the NMR 
spectra the pD was measured again, and no apprecia- 
ble changes were observed. 
Proton NMR spectra were recorded at 37’C, on a 
300 MHz Bruker pulse spectrometer, equipped with 
quadrature detection, using the 90-7-180-r spin- 
echo pulse sequence, 7 being equal to 10 ms. One 
hundred scans were sufficient to obtain adequate sig- 
nal to noise ratio. Some broadening of the bands can 
occasionally occur, but this cannot be attributed to 
kinetic effects, because it disappears when the incuba- 
tion is repeated again. Formation of met-hemoglobin 
or unexpected changes in the physical state of the 
blood sample, coagulation or sedimentation, are more 
probable reasons. 
3. Results 
The pD and the total [2,3-DPG] of the blood sam- 
ples are shown in table 1, where it can be seen that 
the increase in 2,3-DPG level is approximately propor- 
tional to incubation time. 
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Table 1 
pD and [ 2,3-DPG] of blood samples obtained by different 
incubation times at 37°C with inosine (40 mM), inorganic 
phosphate (50 mM) and pyruvate (10 mM) 
Sample Time [ 2,3-DPG] mM pDa 
no. (mW (packed cells) 
lb 180 1.2 7.44 
2 30 6.8 7.62 
3 60 9.5 7.57 
4 120 13.3 7.50 
5 180 17.4 7.44 
a Uncorrected meter readings 
b Blood sample used as a ‘blank’; no substrates added 
1 I 1 I 
9 8 7 6 ppm 
Fig.1. 300 MHz ‘H NMR spectra of intact oxygenated blood 
samples at 37”C, with different [ 2,3-DPG]: (a) 1.2 mM; 
pD 7.44; (b) 6.8 mM; pD 7.62; (c) 17.4 mM; pD 7.44. Peaks 
have been arbitrarily marked with roman numerals for con- 
venience. Letters B-N mark the positions of C2 histidine 
protons in purified oxyhemoglobin [ 171. 
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Spin-echo ‘H NMR spectra of the blood samples 
studied are shown in fig.1 (aromatic region). The posi- 
tions of the peaks observed in purified oxyhemoglo- 
bin [ 171 transformed to our pD (letters B-N) are also 
indicated in the figure, their labelling being main- 
tained. Both spectra show a quite close correspon- 
dence, apart from the lower resolution found in intact 
erythrocyte spectra. Resonances from Cl’ protons of 
sugar rings and C8 protons of purine rings (ATP,ADP) 
are visible on both sides of the spectra, their positions 
being independent of 2,3-DPG level. 
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Fig.2. Chemical shifts of the bands observed in the ‘H NMR 
spectra of intact erythrocytes as a function of [ 2,3-DPG] 
(mM packed cells). The signal from HDO was used as internal 
reference and assigned a value of 6 = 4.63 ppm (TSP) for pur- 
poses of comparison. 
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The most interesting change observed in the spectra 
is the downfield shifting of some bands as [2,3-DPG] 
increases (see fig.2). Bands III and IV move faster 
than band II, while bands V and VI do not move at all. 
Band I also moves downfield, but no information on 
bonded histidines can be obtained, due to the com- 
plexity of this band (resonances from histidine C4 
protons and aromatic protons are included in it). 
4. Discussion 
Although there are slight pD differences among 
the samples (see table l), they cannot be responsible 
for the large shifts observed, because, according to 
reported titration shifts [ 171, none of the peaks is in 
its maximum variation point, so that they should 
experience only slight downfield shifts. Changing the 
pD of the ‘blank’ blood sample from 7.6-7.4, caused 
+6, +4 and +5 Hz shifts in bands VI,V and IV, respec- 
tively, while bands III, II and I remained, within 
experimental error, at the same positions. 
The presence of the deoxy-form could shift down- 
field the ‘H NMR lines of the oxy-form, through a 
rapid exchange between oxy- and deoxy-forms, the 
corresponding lines of the latter being at lower field. 
However, the oxygenated buffer maintains a high par- 
tial pressure of 02, and even at a high [2,3-DPG] inside 
the cell, the fraction of deoxy-form must be very low 
and therefore, the downfield’shifts negligible. 
The possibility that phosphorylated metabolites of 
increasing concentration other than 2,3-DPG, could 
bind to the hemoglobin, must be considered. Only a 
moderate level of Pi is reached in the cells (~4 mM) 
[39], and this level seems not to affect the binding of 
2,3-DPG to the hemoglobin. In fact, no shifts were 
observed in the 2,3-DPG 31P NMR lines when Pi was 
added to model solutions [ 191, and the Pi line itself 
did not shift in intact erythrocytes when the state of 
the hemoglobin changed from oxy to deoxy. The 
small increase of the adenosine triphosphate (ATP) 
level originated by the incubation (-0.2 mM) [39], 
together with the small percentages of binding of oxy- 
hemoglobin to either ATP or ATP-Mg*+ complex 
[41], exclude any significant contribution of this com- 
pound to the observed shifts. Even assuming that other 
minor metabolites, such as, adenosine diphosphate 
(ADP), inosine monophosphate (IMP), 2-phosphogly- 
cerate (2-PG), nicotinamide dinucleotide (NADH), 
bind to oxyhemoglobin with binding constants of the 
same order of magnitude as the 2,3-DPG-oxy con- 
stant, only a small contribution to the shifts is 
expected, because of their low concentration (<l mM). 
From what we have shown above, it follows that 
the main contribution to the observed shifts must be 
the binding of 2,3-DPG to the oxyhemoglobin. Evi- 
dence of that binding by other techniques has been 
reported [25-27,30-341. A rapid exchange between 
the oxy-form and the 2,3-DPG-oxy complex could 
explain the existence of downfield shifts as the 
2,3-DPG level rises in the cell. When 2,3-DPG is 
l-7 mM, only one band is clearly moving downfield, 
namely band III. When 2,3-DPG is 7-l 8 mM, in addi- 
tion to band III, bands IV and II start to move down- 
field, but with different slopes (fig.2). This suggests 
that there is one preferential binding site in oxy- 
hemoglobin;accessible at low 2,3-DPG levels. Other 
binding site(s) involving several histidines are also 
accessible at highlevels of 2,3-DPG, in agreement with 
calorimetric studies [32]. 
As far as we know, peaks in the ‘H NMR spectrum 
of hemoglobin in the oxy-state, have not been assigned 
to individual histidines, so it is not possible to know 
where the binding sites are located within the protein. 
But in any case, it is clear that at least 2 histidines are 
involved in the binding (corresponding to bands III 
and IV), because they exhibit severe downfield shifts. 
At least another histidine (band II) is also affected by 
the binding but to a lesser extent. Assuming that 02 
and 0143 C2 histidine resonances in the oxy-state lie 
near to their positions in the deoxy-form [14] 
(band III), our ‘H NMR spectra support the fact that 
these 2 histidines are involved in binding to the pre- 
ferential site. 
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